To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
The FDA is also investigating reported side effects of aspiration.
Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.
To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid
The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.
The FDA is also investigating reported side effects of aspiration.
Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.